Amanote Research
Register
Sign In
935 Clinical Manifestations and Quality of Life in Patients With Recessive Dystrophic Epidermolysis Bullosa
Journal of Investigative Dermatology
- United Kingdom
doi 10.1016/j.jid.2019.03.1011
Full Text
Open PDF
Abstract
Available in
full text
Categories
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Date
May 1, 2019
Authors
V. Eng
D. Solis
S. Choi
J. Nazaroff
S. Li
J. Tang
Publisher
Elsevier BV
Related search
Recessive Dystrophic Epidermolysis Bullosa Inversa
251 Natural History of Wounds in Patients With Recessive Dystrophic Epidermolysis Bullosa
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
271 From Clinical to Genotypic Modeling: Recessive Dystrophic Epidermolysis Bullosa (RDEB)
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Bone Marrow Transplantation for Recessive Dystrophic Epidermolysis Bullosa
New England Journal of Medicine
Medicine
Gentamicin Induces Functional Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa Patients
Journal of Clinical Investigation
Medicine
Image Gallery: Multiple Localized Lipoatrophy in Recessive Dystrophic Epidermolysis Bullosa
British Journal of Dermatology
Dermatology
Medicine
De Novo Anti-Type VII Collagen Antibodies in Patients With Recessive Dystrophic Epidermolysis Bullosa
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Mesenchymal Stem Cell Therapy for Recessive Dystrophic Epidermolysis Bullosa: Prospects and Clinical Progress
Expert Opinion on Orphan Drugs
Toxicology
Pharmaceutics
Pharmacology
Health Policy
Induced Pluripotent Stem Cells From Individuals With Recessive Dystrophic Epidermolysis Bullosa
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology